ÅLYKKE 14 ApS: Financial statements 2023
CVR: 26110491
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ÅLYKKE 14 ApS (CVR 26110491) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -151,703 and a net result of DKK 721,550 compared with DKK 774,677 the year before. Equity in the 2023 report amounted to DKK 33,760,525. The solvency ratio was 99.7%.
- Gross Profit
- DKK -151,703
- Profit/Loss
- DKK 721,550
- Equity
- DKK 33,760,525
- Total Assets
- DKK 33,874,945
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -152K | 722K | 33.8M | 0 |
| 2022 | - | -69K | 775K | 33.2M | 0 |
| 2021 | - | -90K | 7.2M | 33.7M | 0 |
| 2020 | - | -111K | 2.9M | 26.9M | 0 |
| 2019 | - | 885K | 4M | 26.3M | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ÅLYKKE 14 ApS has published its annual report for 2022. Gross profit came to DKK -68,556, and the net result was DKK 774,677.
About ÅLYKKE 14 ApS
ÅLYKKE 14 ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2001. The company is registered under the industry Speciallægers aktiviteter. The company was previously named KLINIK ÅLYKKE ApS and PBH 27.828 ApS. The management consists of Bent Uhrbrand. The company is owned by Bent Uhrbrand and Anna Bjerrisgård Fransen. The company has 1 employee (2020). In 2025, the company reported a gross profit of DKK -102,224 and a net result of DKK 2,557,290 compared with DKK 2,935,857 the year before. Equity in the 2025 report amounted to DKK 37,768,672.